Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Mechanism of potential new treatment for erectile dysfunction elucidated

Oct. 13, 2000

Role for rho kinase inhibitors in the management of ED

Oct. 11, 2000

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Oct. 11, 2000

Central 5-HT2C receptor agonist exerts proerectile activity in two animal species

Oct. 9, 2000

Vardenafil's preclinical profile supports potential in ED; other PDE5 inhibitors in the pipeline

Oct. 9, 2000

IC-351 effective and safe as once-daily or on-demand therapy for ED

Oct. 6, 2000

Selective V2 receptor agonists from AHP and their use described in patents

Sep. 25, 2000

Recordati identifies potent and selective alpha1D-adrenoceptor antagonists based on BMY-7378

Sep. 21, 2000

Enrollment completed in pivotal phase III trial of Chondrogel

Sep. 21, 2000

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...